A novel prognostic marker and immunogenic membrane antigen: prohibitin (PHB) in pancreatic cancer.

ABSTRACT:

Background

Previous study, using immunoblotting with IgG and membrane proteins, identified prohibitin (PHB) as a potential immunogenic membrane antigen. Now, investigate PHB expression and biological functions in pancreatic cancer.

Methods

PHB expression was analysed in PDAC cell lines, normal pancreas tissues, cancer tissues, PDAC patient sera and healthy volunteer sera using QRT-PCR, Western blotting, IHC, and ELISA, and a survival analysis and a COX regression analysis were performed. Low and high PHB expression levels were accomplished using RNA interference technology and gene transfer techniques. Cell proliferation, migration, and invasion, apoptosis-related proteins were assessed 48 h after transfection.

Results

PHB was generally expressed in the 8 tested PDAC

SUBMITTER: Wang W 

PROVIDER: S-EPMC6125288 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature